Carminati, Laura <br/><br/>
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.  [electronic resource] 

 -  Carcinogenesis  04 2019 
 - 303-312 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2180 
<br/><br/><label>Standard No.: </label>10.1093/carcin/bgy177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Cell Line<br/>Cell Line, Tumor<br/>Female<br/>Macrophages--drug effects<br/>Melanoma--drug therapy<br/>Melanoma, Experimental--drug therapy<br/>Mice<br/>Mice, Inbred C3H<br/>Mice, Inbred C57BL<br/>NIH 3T3 Cells<br/>Neoplasm Metastasis--drug therapy<br/>Skin Neoplasms--drug therapy<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Trabectedin--pharmacology<br/>Tumor Microenvironment--drug effects<br/>Melanoma, Cutaneous Malignant